AVNS vs. ZJYL, ESTA, SMTI, ENOV, PRAX, RLAY, ETNB, OPK, IMTX, and MESO
Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include Jin Medical International (ZJYL), Establishment Labs (ESTA), Sanara MedTech (SMTI), Enovis (ENOV), Praxis Precision Medicines (PRAX), Relay Therapeutics (RLAY), 89bio (ETNB), OPKO Health (OPK), Immatics (IMTX), and Mesoblast (MESO). These companies are all part of the "medical" sector.
Jin Medical International (NASDAQ:ZJYL) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings.
Jin Medical International has higher earnings, but lower revenue than Avanos Medical.
Jin Medical International has a net margin of 0.00% compared to Jin Medical International's net margin of -9.15%. Jin Medical International's return on equity of 4.10% beat Avanos Medical's return on equity.
95.2% of Avanos Medical shares are held by institutional investors. 2.9% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Avanos Medical received 83 more outperform votes than Jin Medical International when rated by MarketBeat users.
Jin Medical International has a beta of 18.8, indicating that its stock price is 1,780% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.
In the previous week, Avanos Medical had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for Avanos Medical and 1 mentions for Jin Medical International. Avanos Medical's average media sentiment score of 1.89 beat Jin Medical International's score of 0.53 indicating that Jin Medical International is being referred to more favorably in the media.
Avanos Medical has a consensus price target of $31.00, indicating a potential upside of 51.89%. Given Jin Medical International's higher possible upside, analysts plainly believe Avanos Medical is more favorable than Jin Medical International.
Summary
Avanos Medical beats Jin Medical International on 9 of the 12 factors compared between the two stocks.
Get Avanos Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Avanos Medical Competitors List
Related Companies and Tools
